These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 16115650

  • 1. Cost-effective G-CSF therapy strategies for cyclical neutropenia: mathematical modelling based hypotheses.
    Foley C, Bernard S, Mackey MC.
    J Theor Biol; 2006 Feb 21; 238(4):754-63. PubMed ID: 16115650
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mathematical model for G-CSF administration after chemotherapy.
    Foley C, Mackey MC.
    J Theor Biol; 2009 Mar 07; 257(1):27-44. PubMed ID: 19007795
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. G-CSF in solid tumor chemotherapy: a tailored regimen reduces febrile neutropenia, treatment delays and direct costs.
    Tsavaris N, Kosmas C, Gouveris P, Vadiak M, Dimitrakopoulos A, Karadima D, Pagouni E, Panagiotakopoulos G, Tzima E, Ispoglou S, Sakelariou D, Koufos C.
    Med Sci Monit; 2004 Feb 07; 10(2):PI24-8. PubMed ID: 14737055
    [Abstract] [Full Text] [Related]

  • 10. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U, Zimmermann M, Lehrnbecher T, Graf N, Hermann J, Niemeyer CM, Reiter A, Ritter J, Dworzak M, Stary J, Reinhardt D.
    J Clin Oncol; 2006 Sep 20; 24(27):4499-506. PubMed ID: 16983120
    [Abstract] [Full Text] [Related]

  • 11. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS, Sen R, Dixit G.
    J Assoc Physicians India; 2008 Dec 20; 56():942-4. PubMed ID: 19322972
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. G-CSF control of neutrophils dynamics in the blood.
    Shochat E, Rom-Kedar V, Segel LA.
    Bull Math Biol; 2007 Oct 20; 69(7):2299-338. PubMed ID: 17554586
    [Abstract] [Full Text] [Related]

  • 14. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E, Castagna L, Sarina B, Mazza R, Magagnoli M, Balzarotti M, Nozza A, Siracusano L, Timofeeva I, Anastasia A, Demarco M, Santoro A.
    Eur J Haematol; 2007 Feb 20; 78(2):111-6. PubMed ID: 17313558
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
    Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL.
    Bone Marrow Transplant; 2007 Aug 20; 40(3):185-92. PubMed ID: 17563736
    [Abstract] [Full Text] [Related]

  • 16. Multistability in an age-structured model of hematopoiesis: Cyclical neutropenia.
    Lei J, Mackey MC.
    J Theor Biol; 2011 Feb 07; 270(1):143-53. PubMed ID: 21094168
    [Abstract] [Full Text] [Related]

  • 17. MPGN type I induced by granulocyte colony stimulating factor.
    Magen D, Mandel H, Berant M, Ben-Izhak O, Zelikovic I.
    Pediatr Nephrol; 2002 May 07; 17(5):370-2. PubMed ID: 12042897
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer.
    Timmer-Bonte JN, Adang EM, Smit HJ, Biesma B, Wilschut FA, Bootsma GP, de Boo TM, Tjan-Heijnen VC.
    J Clin Oncol; 2006 Jul 01; 24(19):2991-7. PubMed ID: 16682725
    [Abstract] [Full Text] [Related]

  • 20. Febrile neutropenia, colony-stimulating factors and therapy: time for a new methodology?
    Forrest GN, Schimpff SC, Cross A.
    Support Care Cancer; 2002 Apr 01; 10(3):177-80. PubMed ID: 11904781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.